SimplePeptide's CJC-1295 + Ipamorelin pen contains 10 mg of each named ingredient, 20 mg combined, and is listed at IDR 3,000,000. The two names describe a blend. They do not, on their own, resolve the exact CJC-1295 construct or establish a particular combined result.
If you have seen “with DAC,” “without DAC” and “CJC/IPA” used as though they were interchangeable, start by checking the full identity rather than the abbreviation.
What each part of the name contributes
CJC-1295 was investigated as a long-acting analogue of growth-hormone-releasing hormone. Ipamorelin was investigated as a growth-hormone-releasing peptide. Their separate human studies measured hormone responses under defined conditions: CJC-1295 trial and ipamorelin pharmacology study.
That shared interest in GH biology explains why the names appear together. It is not a demonstration that the finished blend improves every outcome associated with growth hormone.
Why the DAC detail belongs in the documents
The long-acting CJC-1295 research involved an albumin-binding construct. Commercial naming can be less precise. If a product page does not establish the relevant identity, do not infer it from a familiar short name or borrow a duration from a different preparation.
Ask for the applicable identity documentation. The answer should describe the product being sold, not merely link to a study of a similarly named substance.
Read 10 + 10 as a composition, not a schedule
| Number or phrase | Meaning |
|---|---|
| 10 mg CJC-1295 | Labelled total amount of that component |
| 10 mg Ipamorelin | Labelled total amount of that component |
| 20 mg combined | Sum of the component amounts |
| Owner usage estimate | A shopping comparison assumption, not product-specific dosing or stability evidence |
Neither the combined total nor the ratio supplies an individual administration plan. A study's route and timing are also not instructions for a different commercial presentation.
Compare the outcome being advertised
A hormone measurement, a strength test, sleep quality and a change in body composition answer different questions. When an advertisement promises one of the latter outcomes, look for a study that measured it in an appropriate population using the actual combination.
For the commercial comparison, the CJC-1295 + Ipamorelin page provides the pen details. COMEBACK MODE pairs it with BPC-157 + TB-500; NIGHT SHIFT pairs it with Tesamorelin. Their contents and savings are shown on the bundles page.
A bundle name can make a pair easier to find. It is not a clinical programme or proof of synergy. Resolve ingredient identity first, then compare the exact pens and total price you are considering.
Sources are linked beside the statements they support. Product prices and specifications were checked on 16 October 2026; confirm current details on the product page.